Molecular Endocrinology, Vol 10, 1227-1237, Copyright © 1996 by Endocrine Society

ARTICLES

Dexamethasone stimulation of rat insulin-like growth factor binding protein-1 promoter activity involves multiple cis-elements

DS Suh, Y Zhou, GT Ooi and MM Rechler
Growth and Development Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

Insulin-like growth factor binding protein-1 (IGFBP-1) modulates the mitogenic actions of IGF-I and IGF-II. Dexamethasone increases IGFBP-1 mRNA abundance and gene transcription in rat liver and in H4-II-E rat hepatoma cells. A glucocorticoid response element (GRE) located at nucleotide (nt) -91/-77 is required for dexamethasone to stimulate rat IGFBP-1 promoter activity in transient transfection assays in H4-II-E cells. Mutagenesis of nt -108/-99 (the M4 region of the insulin response element), however, decreased dexamethasone-stimulated promoter activity despite the presence of an intact GRE, suggesting that regulatory sites in addition to the GRE were required for optimal dexamethasone stimulation. To identify these sites, we introduced 5'- deletion and substitution mutations into rat IGFBP-1 promoter fragments coupled to a luciferase reporter gene and transfected these constructs into H4-II-E cells. Three sites are required for optimal basal promoter activity: a site (nt -62/-50) that binds the liver-enriched transcription factor, hepatocyte nuclear factor-1 (HNF-1), the M4 site, and a putative binding site for transcription factor AP-2 (nt -293/- 286). The HNF-1 and M4 sites and an upstream site (nt -252/-236) are also involved in dexamethasone stimulation under some, but not all, circumstances. Mutation of either the HNF-1 site or the M4 site decreased dexamethasone stimulation by more than 80% in constructs whose 5'-end was at nt -92, -135, or -235 but not if the 5' -end was at nt -278 or -327. These results suggest that the nt -278/-236 region can compensate for the loss of the HNF-1 site or the M4 site but that the HNF-1 and M4 sites do not compensate for each other in constructs whose 5'-end was at nt -135 or -235, which lack the nt -278/-236 region. The site within the nt -278/-236 region was localized to nt -252/-236 by deoxyribonuclease I protection and transfection assays. Thus, several cis-elements in the rat IGFBP-1 promoter cooperate, in varying combinations, with the low-affinity GRE to allow optimal dexamethasone- stimulated promoter activity.

This article has been cited by other articles:

				A. D. Smith, P. Sumazin, and M. Q. Zhang Identifying tissue-selective transcription factor binding sites in vertebrate promoters PNAS, February 1, 2005; 102(5): 1560 - 1565. [Abstract] [Full Text] [PDF]

				W.-C. Tsai, N. Bhattacharyya, L.-Y. Han, J. A. Hanover, and M. M. Rechler Insulin Inhibition of Transcription Stimulated by the Forkhead Protein Foxo1 Is Not Solely due to Nuclear Exclusion Endocrinology, December 1, 2003; 144(12): 5615 - 5622. [Abstract] [Full Text] [PDF]

				V. Perrot and M. M. Rechler Characterization of Insulin Inhibition of Transactivation by a C-terminal Fragment of the Forkhead Transcription Factor Foxo1 in Rat Hepatoma Cells J. Biol. Chem., July 3, 2003; 278(28): 26111 - 26119. [Abstract] [Full Text] [PDF]

				A. Menendez-Hurtado, A. Santos, and A. Perez-Castillo Characterization of the Promoter Region of the Rat CCAAT/Enhancer-Binding Protein {alpha} Gene and Regulation by Thyroid Hormone in Rat Immortalized Brown Adipocytes Endocrinology, November 1, 2000; 141(11): 4164 - 4170. [Abstract] [Full Text] [PDF]

				M. Tomizawa, A. Kumar, V. Perrot, J. Nakae, D. Accili, and M. M. Rechler Insulin Inhibits the Activation of Transcription by a C-terminal Fragment of the Forkhead Transcription Factor FKHR. A MECHANISM FOR INSULIN INHIBITION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 TRANSCRIPTION J. Biol. Chem., March 15, 2000; 275(10): 7289 - 7295. [Abstract] [Full Text] [PDF]

				G. Schweizer-Groyer, N. Jibard, E. Neau, D. Fortin, F. Cadepond, E.-E. Baulieu, and A. Groyer The Glucocorticoid Response Element II Is Functionally Homologous in Rat and Human Insulin-like Growth Factor-binding Protein-1 Promoters J. Biol. Chem., April 23, 1999; 274(17): 11679 - 11686. [Abstract] [Full Text] [PDF]

				H. Ren and G. L. Stiles Dexamethasone Stimulates Human A1 Adenosine Receptor (A1AR) Gene Expression through Multiple Regulatory Sites in Promoter B Mol. Pharmacol., February 1, 1999; 55(2): 309 - 316. [Abstract] [Full Text]

				R. S. Streeper, E. M. Eaton, D. H. Ebert, S. C. Chapman, C. A. Svitek, and R. M. O'Brien Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription PNAS, August 4, 1998; 95(16): 9208 - 9213. [Abstract] [Full Text] [PDF]

				M. Li, X. Ye, R. N. Woodward, C. Zhu, L. A. Nichols, and L. J. Holland Analysis of the DNA-binding Site for Xenopus Glucocorticoid Receptor Accessory Factor. CRITICAL NUCLEOTIDES FOR BINDING SPECIFICITY IN VITRO AND FOR AMPLIFICATION OF STEROID-INDUCED FIBRINOGEN GENE TRANSCRIPTION J. Biol. Chem., April 17, 1998; 273(16): 9790 - 9796. [Abstract] [Full Text] [PDF]

				D.-S. Suh and M. M. Rechler Hepatocyte Nuclear Factor 1 and the Glucocorticoid Receptor Synergistically Activate Transcription of the Rat Insulin-like Growth Factor Binding Protein-1 Gene Mol. Endocrinol., November 1, 1997; 11(12): 1822 - 1831. [Abstract] [Full Text]

				A. S. Kumar, V. C. Venkatesh, B. C. Planer, S. I. Feinstein, and P. L. Ballard Phorbol Ester Down-regulation of Lung Surfactant Protein B Gene Expression by Cytoplasmic Trapping of Thyroid Transcription Factor-1 and Hepatocyte Nuclear Factor 3 J. Biol. Chem., August 15, 1997; 272(33): 20764 - 20773. [Abstract] [Full Text] [PDF]